Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin (PINK)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2013 by University of Rochester.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Gladys Velarde, University of Rochester
ClinicalTrials.gov Identifier:
NCT01785615
First received: February 1, 2013
Last updated: February 7, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2013
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)